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Objectives. The aim of this study was to evaluate mid-term results of endovascular treatment of penetrating aortic ulcers.
Methods. Between February 2000 and November 2006, 18 consecutive patients underwent endovascular treatment of the
descending thoracic aorta (N¼ 16) and abdominal infrarenal aorta (N¼ 2) for penetrating aortic ulcer, in a single
University Hospital. Data were prospectively collected and retrospectively analyzed. Mean follow-up was 41 months
(range 4 to 77 months).
Results. Technical success was achieved in all patients. No perioperative deaths occurred. No conversion to open repair or
secondary procedures were required. Two patients died in the follow-up period for reasons not related to penetrating aortic
ulcers. One type II endoleak was observed. It was still present, unchanged, twelve months after the procedure.
Conclusion. Endovascular treatment of penetrating aortic ulcers of the descending thoracic and infrarenal aorta were safe
and effective in the mid-term in this small series of patients.
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Penetrating Aortic Ulcer (PAU), intramural hematoma,
and aortic dissection are the three entities of the acute
aortic syndrome.1 These three, etiologically different
conditions, are closely related due to the similar clinical
presentation and eventual catastrophic progression.1
PAU can progress to intramural hematoma, which
can progress to aortic dissection. PAU can also directly
progress to aortic dissection, or aneurysm/pseudo-
naeurysm formation, or aortic perforation.
Shennan2 first described PAU of the thoracic aorta
in 1934. The natural history of the disease remains
unclear and little information is available in the liter-
ature.3,4 In 1959, Shumacker and King5 reported the
first successful surgical repair of a ruptured descend-
ing aorta caused by a PAU. Surgical management of
PAU is associated with a mortality of 5% to 20%.6 Tho-
racic and abdominal aortic endografting is routinely
performed for aneurysmal and dissection disease in
many specialized centers around the world, and is
associated with less peri-procedural morbidity and
mortality.7,8 The aim of this study was to evaluate
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Materials and Methods
Patients
From February 2000 to November 2006, 18 consecu-
tive patients underwent endovascular treatment of
the descending thoracic aorta (N¼ 16) and abdominal
infrarenal aorta (N¼ 2) for PAU. All patients were
symptomatic for aortic pain at admission. Non symp-
tomatic patients with accidental findings of aortic
lesions were not included in this study.
Initially, medical treatment was offered to 16 patien-
ts with PAU by means of aggressive anti-hypertension
therapy and analgesic agents with b-blockers, nitro-
prussate, painkillers, continuous electrocardiogram
and continuous non-invasive arterial pressure mea-
surements in a high dependancy unit. Two patients
presented with contained ruptures and peri-aortic
haematoma of the descending aorta limited to the peri-
adventitial space were included in the study and were
treated in emergency conditions with stent-grafting.
Aortic imaging at admission and every 24 hours
for monitoring of eventual progression of the lesionrved.
75Endovascular Treatment of Penetrating Aortic Ulcerswas also performed. Intramural haematoma was
associated in 4 patients with descending thoracic
PAU. The mean longitudinal extension was 2.8 cm.
Median time between admission and stent grafting
was 2 days (range 1e4 days).
Indications for treatment included chest pain in
4 patients (22.2%), back pain in 8 patients (44.5%), com-
bined chest and back pain in 4 patients (22.2%) and
abdominal pain in 2 (11.1%) patients. Patients with
intramural hematoma or classic aortic dissection, or
predominantly aneurysmal dilatation were excluded
for the study. Mean time between admission and treat-
ment in the 16 stable patients was 3 days 2 days.
Written informed consent for vascular access and
stent-graft placement was obtained from every patient.
Aortic imaging
All patients underwent a pre-interventional trans-
thoracic echocardiography for cardiological function
evaluation, combined with contrast-enhanced ECG-
gated multidetector computed tomography or magnetic
resonance angiography. Transesophageal echocardi-
ography was performed intraoperatively in 3 patients
(16.6%). Digital subtracted aortography was performed
in all patients intraoperatively. Follow-up imaging
was obtained with contrast-enhanced computed
tomography or magnetic resonance angiography in
all patients.
Endografts
Thoracic aortic endografts included ENDOFIT (En-
domed, Phoenix, AR) in 6 patients, TALENT (Med-
tronic, Sunrise, FL) in 4 patients, TAG (W.L. Gore and
Associates, Flagstaff, AZ) in 4 patients, and RELAY
(Bolton Medical Inc, Sunrise, FL) in 2 patients. The re-
maining 2 patients with abdominal PAU, were treated
with the POWERLINK (Endologix Inc, Irvine, Calif)
endograft. The size of the introducer sheath and the de-
livery system ranged between 20F and 24F. The stent-
grafts were available in standard configurations in all
patients. A maximum 10% oversizing of the devices
was performed.
Procedure
All interventionswereperformedby endovascular spe-
cialists that included vascular surgeons trained in en-
dovascular therapy and interventional cardiologists
experienced in aortic endografting. Vascular surgeons
performed 5 procedures in the operating theater with
a portable C-arm fluoroscopic device with roadmapcapability, while interventional cardiologists per-
formed 13 procedures in the cardiac catheterization
laboratory.
Patients were prepared in the supine position with
the left arm extended to allow access to the brachial ar-
tery if needed. Ten patients were treated under general
anesthesia and 8 under epidural anesthesia. The opera-
tive field was prepared under sterile conditions.
Ceftriaxone 2 g intravenous was administered to all
patients prior to the procedure. Femoral cut-downwas
performed in all patients, while in one patient retroper-
itoneal approach to the right iliac artery, and in another
onedirect access to the aorta andattachment of a 10 mm
Hemashield graft (Boston Scientific, Natick, MA) were
necessary for severe iliac arteries calcifications.
Systemic heparinization with 5000 IU was admi-
nistrated. A two projection angiogram was obtained
using a 6F pigtail catheter. The devices were advanced
over a 0.035’’ ultrastiff wire Amplatz or Back-up Meir
(Boston Scientific, Natick, MA). The devices were de-
ployed under fluoroscopic guidance in all patients,
combined with echografic (transesophageal) guidance
in 3 patients.
Follow-up
All patients underwent a strict follow-up protocol that
combined clinical examination and aortic imagingwith
contrast enhanced computed tomography or magnetic
resonance angiography before discharge, at 3, 6, 12
moths after the procedure, and annually thereafter.
Definitions and statistics
PAU (Fig. 1) was defined as at least one focal contrast
material-filled, craterlike outpouching of the endolu-
minal border of the aorticwall and penetrating the lam-
ina elastica interna localized in an area of significant
atheroma. Patients’ clinical health status were evalu-
ated according to the classification of the American
Society of Anesthesiologists.9 Procedural success was
defined by successful deployment of the device in the
target vessel. Primary success rate was defined as com-
plete exclusion of the lesion without signs of endoleak.
Data were analyzed using the SPSS software pack-
age for windows version 13.0 (SPSS Inc, Chicago, Ill).
The Kaplan-Meier non-parametric method was used
to estimate survival in time.
Results
Patients’ characteristics are presented in the Table 1.
Fourteen patients had a single focal lesion (Fig. 2A),
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1e3). Median crater diameter was 1.2 cm (range
0.5 cm to 2 cm). In all patients a proximal and a distal
aortic neck of at least 2 cm of length was present. In
two patients the lesionwas complicated with pseudoa-
neurysm formation of 3.6 cm and 4.2 cm, while one
patient had contemporary PAU complicated with
pseudoaneurysm formation, and an acute coronary
syndrome. He was treated with a combined approach
excluding the PAU and the pseudoaneurysm with
a double TAG device, and stenting the circumflex
coronary artery. Aortic pain was persistent in 16 of 18
patients even after medical treatment.
Technical successwas achieved in all patients. In 7 of
the 16 patients with descending thoracic aorta PAUwe
deployed two stent-grafts to cover the entire lesion,
while in the other 9, a single piece was used. The 2
patients with abdominal PAU receive the one-piece
non-modular Endologix stent-graft with no cuff
Fig. 1. Penetrating aortic ulcers as shown in the angiogram.
Table 1. Preoperative patients’ characteristics
Preoperative Characteristics N (%)
Age 68.6 8.2
Gender (Male) 16 (88.9)
Hypertension 18 (100)
Dislipidemia 9 (50)
Diabetes mellitus 3 (16.7)
Smoking history 11 (61.1)




Coronary artery disease 5 (27.8)
Congestive heart failure 1 (5.6)
Previous cardiac surgery 1 (5.6)
Previous carotid surgery 1 (5.6)
ASA III 4 (22.2)
ASA IV 14 (77.8)
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formed in order to facilitate the crossing of the device.
In the 4 patients with PAU associated with intramural
haematoma, the haematoma was completely covered
by the stent-graft. There was only one type II endoleak
in the patient with angina and aortic pain treated with
coronary angioplasty and stent-grafting. However, he
remained asymptomatic for angina or aortic pain
after combined treatment, and it was decided to adopt
a conservative approach with antipertensive therapy.
In all patients, symptomatic relief from pain was
observed after the procedure. There were no peri-
operative cardiac events, paraplegias, strokes or other
major complications. In 7 patients systemic inflamma-
tory reaction was observed with moderate fever in
6 of them (37.5 C to 38.5 C) for 24 to 36 hours, and
severe fever (39.5 C to 40.5 C) in one patient lasting
48 hours. Fever was treated with paracetamol. Median
hospital stay was 6 days (range 4 to 11).
Mean follow-up was 41 months (range 4 to 77
months). One death occurred during the follow-up pe-
riod frommyocardial infraction and a second one from
neoplastic disease giving a late mortality rate of 11.1%
(Fig. 3). No PAU-related deaths were observed. The
type II endoleak was persistent at 3 months and 6
months follow-up but asymptomatic and with stable
very small diameter. In the other 17 cases the crater of
the ulcer remained thrombosed. All 4 intramural hae-
matomas were thrombosed at the 3-month imaging
control. There were no treatment failures and no
additional interventions required. There was no late
pseudoaneurysm formation, nor aorto-bronchial or
aorto-esophageal fistulae.
Discussion
When Stanson et al10 in 1986 described PAUs, it was
thought to have a particularlymalignant behavior war-
ranting an aggressive surgical treatment. However,
shortly thereafter, Hussain et al11 presented evidence
for successful medical treatment in selected cases,
whereas other authors supported that PAUhas aworse
prognosis than classic aortic dissection.12 Choe et al13
concluded that many PAU can be managed nono-
peratively in the acute setting, but he noticed that at
least one third of these patients will undergo an early
operation. In the same study,13 85% of the cases with
associated intramural haematoma spontaneously
thrombosed after one year.
Open surgical repair of the descending aorta requi-
res a large thoracotomy, possible14 cardiopulmonary
bypass, prolonged mechanical ventilation, and clamp-
ing of the aorta. Endovascular surgery in contrast,
77Endovascular Treatment of Penetrating Aortic UlcersFig. 2. A. Single penetrating aortic ulcer. The arrow shows the lesion. B. Multiple penetrating aortic ulcers. The arrows are
showing the lesions.generally requires only femoral access and rarely iliac,
and no aortic clamping. Operation time is shorter, the
procedure is less invasive and has the potential of sig-
nificantly reducing peri-operative mortality and mor-
bidity. If it is proven to be as effective as surgery it
could be the treatment of choice for these lesions.
In patients with PAU the aorta is characterized by
a generalized inflammatory process and the vessel is
considered to be fragile.1,13 Therefore some authors15
have proposed treating PAU in the subacute phase in
order to avoid risks related to fragility, such as aortic
perforation from the device and late pseudoaneurysm
Fig. 3. Kaplan-Meier function.Mid-term survival estimation.formation. Moreover, the association with intramural
haematoma is considered the main cause of aneurysm
formation at the distal stent-graft sites.1 In sixteen sta-
ble patients this strategy was preferred, offering at first
aggressive medical treatment, while the two patients
with the contained ruptures underwent endografting
within 24 hours from admission. For the same reasons
endograftswith low radial force (6 of the 16 thoracic en-
dografts were Endofit), and with a maximum oversiz-
ing of 10% were preferred. This strategy gave no case
of aortic perforation or late pseudoaneurysm forma-
tion. Despite advanced age and highASA classification
(Table 1) there was zero perioperative mortality, and
the two deaths achieved in the follow-up period were
non-PAU related. These data compare favourably
with many other reports,3,16e18 indicating that endo-
vascular treatment is very suitable for thePAUpatients’
population.
PAU occurs predominantly in the descending tho-
racic aorta and is uncommon in abdominal aorta. To
our knowledge, 46 abdominal PAUs have been re-
ported in the literature until now.4 Twelve of them
treated medically, 25 with open surgery and 9 with
endografting. In a series of 234 abdominal aortic pro-
cedures, 8 were performed for abdominal PAU giving
an incidence of 3.4%.4 In our study two abdominal
PAU were observed among 18 total PAUs giving an
incidence of 11.1% of all PAUs.
Magnetic resonance angiography is proposed as
the method of choice in patients with PAU by some
authors.19 It gives excellent anatomical and functional
information. However, it is of little value in identifica-
tion of intramural haematoma and wall calcification,
and it is less practical in the acute setting, and gives
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syndromes can be associated in patients with acute
aortic syndromes,20 and this is confirmed in the pres-
ent study that includes a patient with combined treat-
ment. New generation multidetector computer
tomography with ECG-gating capability is more prac-
tical in the acute setting because it reduces signifi-
cantly the time required for image acquisition, and
has the advantage of contemporary evaluation of cor-
onary circulation. Artefacts are significantly reduced
by ECG-gating software and many authors recom-
mend it as the imaging technique of first choice in
patients with PAU.21,22
Transesophageal echocardiography was not rou-
tinely used although it can be very useful in the defini-
tion and localization of the lesion. It is however an
invasive imaging technique and requires general anes-
thesia.Aortographyhas avery low sensitivity rate. This
study has the limitations of a retrospective analysis,
even if datawere collected prospectively. Themain lim-
itation is the small number of patients that restricts any
statistical analysis. PAU is an infrequent disease and
therefore large series of patients are lacking in the liter-
ature. It is however diagnosed more often nowadays
thanks to new refined imaging techniques. Large mul-
ticenter registries on PAU could help in better under-
standing the natural history, epidemiology and best
treatment option of these particular lesions.
Conclusions
In these series of patients, endovascular treatment
proved safe and effective in treating patients with
PAU of the descending thoracic aorta and the abdomi-
nal infrarenal aorta inmid-term follow-up.Multicenter
prospective registries are required to define the natural
history of the disease and validate the long-term dura-
bility of endovascular treatment, that in our opinion
should be the first-choice option in anatomically suit-
able patients.
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